One hundred and forty-seven patients with essential hypertension participated in this multicentre study. The results indicate that metoprolol in a dosage of 150-450 mg daily is an effective and well tolerated therapy both in patients previously untreated and in patients unsatisfactorily treated with other antihypertensive agents.
Get full access to this article
View all access options for this article.
References
1.
AbladBCarlssonEEkL (1973) Pharmacological studies of two new cardio-selective adrenergic beta-receptor antagonists. Life Sciences12, 107
2.
AngervallGBystedtU (1974) The effect of alprenolol and alprenolol in combination with saluretics in hypertension. Acta Medica Scandinavica Suppl 554, 39
3.
BengtssonC (1972) Comparison between alprenolol and chlorthalidone as antihypertensive agents. Acta Medica Scandinavica191, 433
4.
BengtssonC (1976a) The effect of metoprolol—a new selective adrenergic beta1-receptor blocking agent—in mild hypertension. Acta Medica Scandinavica199, 65
5.
BengtssonC (1976b) Comparison between metoprolol and propranolol as antihypertensive agents. A double-blind crossover study. Acta Medica Scandinavica199, 71
6.
CastenforsJJohnssonHOröL (1973) Effect of alprenolol on blood pressure and plasma renin activity in hypertensive patients. Acta Medica Scandinavica193, 189
7.
FelixRHIveFADahlMGD (1974) Cutaneous and ocular reactions to practolol. British Medical Journal4, 321
8.
JohnssonG (1975) Influence of metoprolol and propranolol on hemodynamic effects induced by adrenaline and physical work. Acta Pharmacologica et Toxicologica36, suppl 5, 59
9.
JohnssonGSvedmyrNThiringerG (1975) Effects of intravenous propranolol and metoprolol and their interaction with isoprenaline on pulmonary function heart rate and blood pressure in asthmatics. European Journal of Clinical Pharmacology8, 175
10.
JäätteläAPyöräläK (1976) A controlled study on the antihypertensive effect of a new beta adrenergic receptor blocking drug, metoprolol, in combination with chlorthalidone. British Journal of Clinical Pharmacology3, 655
11.
KatilaMFrickMH (1970) Combined dihydrallazine and propranolol in the treatment of hypertension. International Journal of Clinical Pharmacology4, 111
12.
PedersenO Lederballe (1976) Comparison of metoprolol and hydrochlorothiazide as antihypertensive agents. European Journal of Clinical Pharmacology10, 381
13.
MorganTOSabtoJAnavekarSNLouisWJDoyleAE (1974) A comparison of beta adrenergic blocking drugs in the treatment of hypertension. Postgraduate Medical Journal50, 253
14.
PapeJ (1974) The effect of alprenolol in combination with hydrallazine in essential hypertension. Acta Medica Scandinavica Suppl 554, 55
15.
PrichardBNCGillamPMS (1969) Treatment of hypertension with propranolol. British Medical Journal1, 7
16.
SannerstedtRStenbergJVedinAWilhelmssonCWerköL (1972) Chronic beta adrenergic blockade in arterial hypertension. Hemodynamic influences of dihydrallazine and dynamic exercise and clinical effects of combined treatment. American Journal of Cardiology29, 718
17.
SiegelS (1956) Non-parametric statistics. McGraw-Hill, New York
18.
StokkelandOMSangvikKDitlefsenEM Lindseth (1975) A comparative study of metoprolol and trichlormethiazide in hypertension. Current Therapeutic Research18, 755
19.
ThiringerGSvedmyrN (1976) Interaction of orally administered metoprolol, practolol and propranolol with isoprenaline in asthmatics. European Journal of Clinical Pharmacology10, 163
20.
TibblinGAbladB (1969) Antihypertensive therapy with alprenolol, a β-adrenergic receptor antagonist. Acta Medica Scandinavica186, 451
21.
Waal-ManningHJ (1970) Comparative studies of the hypotensive effects of beta adrenergic receptor blockers. In: Beta adrenergic Receptor Blocking Drugs. (Ed by Simpson) p 64, Australasian Drug Information Services Pty Ltd.
22.
WindsorWOKurreinFDyerNH (1975) Fibrinous peritonitis. A complication of practolol therapy. British Medical Journal2, 68
